TCC New Distributor for Emerald K-Flex

Emerald Kalama Chemical, a business unit of Emerald Performance Materials (EPM,) has selected The Chemical Company (TCC) as US distributor for its K-Flex line of dibenzoate-based plasticizers.

Emerald is based at Kalama, Washington, on the US west coat and TCC at Jamestown, Rhode Island on the east coast.

The EPM offshoot said the distribution partnership will extend its market reach. For TCC, the addition of the K-Flex products will bolster and add value to its already extensive ester product line.

The K-Flex dibenzoate multi-purpose products includes numerous applications in coatings, sealants, caulks, flexible vinyl and adhesives sold as K-Flex 850S, K-Flex 850P, K-Flex 500, K-Flex 500P, K-Flex 975P, K-Flex PG, and K-Flex DP.

Emerald Chemical said the plasticizer line is “an excellent phthalate-free solution for formulators looking to satisfy environmentally friendly, non-SVHC, low VOC plasticizers and coalescents.”

EPM was formed in 2006 from the divestiture of certain Lubrizol businesses. Since its formation, the company has nearly doubled in size and now has eight manufacturing locations and more than 800 employees.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.